256 related articles for article (PubMed ID: 34040104)
1. Cooperative inhibition of SNARE-mediated vesicle fusion by α-synuclein monomers and oligomers.
Yoo G; Yeou S; Son JB; Shin YK; Lee NK
Sci Rep; 2021 May; 11(1):10955. PubMed ID: 34040104
[TBL] [Abstract][Full Text] [Related]
2. Large α-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking.
Choi BK; Choi MG; Kim JY; Yang Y; Lai Y; Kweon DH; Lee NK; Shin YK
Proc Natl Acad Sci U S A; 2013 Mar; 110(10):4087-92. PubMed ID: 23431141
[TBL] [Abstract][Full Text] [Related]
3. Nonaggregated α-synuclein influences SNARE-dependent vesicle docking via membrane binding.
Lai Y; Kim S; Varkey J; Lou X; Song JK; Diao J; Langen R; Shin YK
Biochemistry; 2014 Jun; 53(24):3889-96. PubMed ID: 24884175
[TBL] [Abstract][Full Text] [Related]
4. α-Synuclein may cross-bridge v-SNARE and acidic phospholipids to facilitate SNARE-dependent vesicle docking.
Lou X; Kim J; Hawk BJ; Shin YK
Biochem J; 2017 Jun; 474(12):2039-2049. PubMed ID: 28495859
[TBL] [Abstract][Full Text] [Related]
5. The Role of α-Synuclein in SNARE-mediated Synaptic Vesicle Fusion.
Yoo G; Shin YK; Lee NK
J Mol Biol; 2023 Jan; 435(1):167775. PubMed ID: 35931109
[TBL] [Abstract][Full Text] [Related]
6. β-Amyloid and α-synuclein cooperate to block SNARE-dependent vesicle fusion.
Choi BK; Kim JY; Cha MY; Mook-Jung I; Shin YK; Lee NK
Biochemistry; 2015 Mar; 54(9):1831-40. PubMed ID: 25714795
[TBL] [Abstract][Full Text] [Related]
7. Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations.
Lewis KA; Yaeger A; DeMartino GN; Thomas PJ
J Bioenerg Biomembr; 2010 Feb; 42(1):85-95. PubMed ID: 20148295
[TBL] [Abstract][Full Text] [Related]
8. α-Synuclein Disrupts Vesicle Fusion by Two Mutant-Specific Mechanisms.
Yoo G; An HJ; Yeou S; Lee NK
Mol Cells; 2022 Nov; 45(11):806-819. PubMed ID: 36380732
[TBL] [Abstract][Full Text] [Related]
9. Alpha-Synuclein defects autophagy by impairing SNAP29-mediated autophagosome-lysosome fusion.
Tang Q; Gao P; Arzberger T; Höllerhage M; Herms J; Höglinger G; Koeglsperger T
Cell Death Dis; 2021 Sep; 12(10):854. PubMed ID: 34535638
[TBL] [Abstract][Full Text] [Related]
10. The N-terminal residues 43 to 60 form the interface for dopamine mediated α-synuclein dimerisation.
Leong SL; Hinds MG; Connor AR; Smith DP; Illes-Toth E; Pham CL; Barnham KJ; Cappai R
PLoS One; 2015; 10(2):e0116497. PubMed ID: 25679387
[TBL] [Abstract][Full Text] [Related]
11. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
El-Agnaf OM; Paleologou KE; Greer B; Abogrein AM; King JE; Salem SA; Fullwood NJ; Benson FE; Hewitt R; Ford KJ; Martin FL; Harriott P; Cookson MR; Allsop D
FASEB J; 2004 Aug; 18(11):1315-7. PubMed ID: 15180968
[TBL] [Abstract][Full Text] [Related]
12. Altered Distribution of SNARE Proteins in Primary Neurons Exposed to Different Alpha-Synuclein Proteoforms.
Brolin E; Ingelsson M; Bergström J; Erlandsson A
Cell Mol Neurobiol; 2023 Aug; 43(6):3023-3035. PubMed ID: 37130995
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
Vaikath NN; Majbour NK; Paleologou KE; Ardah MT; van Dam E; van de Berg WD; Forrest SL; Parkkinen L; Gai WP; Hattori N; Takanashi M; Lee SJ; Mann DM; Imai Y; Halliday GM; Li JY; El-Agnaf OM
Neurobiol Dis; 2015 Jul; 79():81-99. PubMed ID: 25937088
[TBL] [Abstract][Full Text] [Related]
14. Dopamine-mediated oxidation of methionine 127 in α-synuclein causes cytotoxicity and oligomerization of α-synuclein.
Nakaso K; Tajima N; Ito S; Teraoka M; Yamashita A; Horikoshi Y; Kikuchi D; Mochida S; Nakashima K; Matsura T
PLoS One; 2013; 8(2):e55068. PubMed ID: 23457458
[TBL] [Abstract][Full Text] [Related]
15. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
Sahay S; Ghosh D; Singh PK; Maji SK
Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional properties of prefibrillar α-synuclein oligomers.
Pieri L; Madiona K; Melki R
Sci Rep; 2016 Apr; 6():24526. PubMed ID: 27075649
[TBL] [Abstract][Full Text] [Related]
17. A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α-synuclein research.
Kumar ST; Donzelli S; Chiki A; Syed MMK; Lashuel HA
J Neurochem; 2020 Apr; 153(1):103-119. PubMed ID: 31925956
[TBL] [Abstract][Full Text] [Related]
18. Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization.
Samuel F; Flavin WP; Iqbal S; Pacelli C; Sri Renganathan SD; Trudeau LE; Campbell EM; Fraser PE; Tandon A
J Biol Chem; 2016 Feb; 291(9):4374-85. PubMed ID: 26719332
[TBL] [Abstract][Full Text] [Related]
19. The interplay between lipids and dopamine on α-synuclein oligomerization and membrane binding.
Pham CL; Cappai R
Biosci Rep; 2013 Oct; 33(5):. PubMed ID: 24066973
[TBL] [Abstract][Full Text] [Related]
20. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A
Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
